Navigation Links
Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
Date:2/12/2008

TUSTIN, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing targeted therapies for the treatment of cancer and hepatitis C virus infection (HCV), today announced that patient dosing has begun in its clinical trial designed to evaluate the safety and efficacy of bavituximab in combination with chemotherapy in patients with advanced breast cancer. The primary objective of the study is to assess the overall response rate to the combination of bavituximab with docetaxel, a chemotherapy drug commonly used in breast cancer. The multicenter clinical trial is being conducted in the Republic of Georgia.

"We are now seeing good overall momentum in our bavituximab Phase II cancer program, and we are very pleased that our clinical colleagues in Europe have been so efficient in rapidly moving from protocol approval to trial initiation to patient dosing," said Steven W. King, president and CEO of Peregrine. "We are optimistic that all three bavituximab Phase II cancer trials will proceed well in the coming months and we look forward to reporting on our progress later this year."

In the trial's two-stage design, up to 15 patients with advanced breast cancer will be enrolled initially. The study will then be expanded up to a total of 46 patients if promising results are observed. Secondary objectives include measuring time to tumor progression, duration of response, overall patient survival and safety parameters. Patients may continue to receive bavituximab alone after completion of chemotherapy as long as the cancer does not progress and side effects are acceptable.

"Bavituximab represents a novel strategy for the treatment of cancer that has
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
2. Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008
3. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program
4. Peregrine Pharmaceuticals to Announce Second Quarter FY 2008 Financial Results
5. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
6. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
9. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
10. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
11. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008).../ -- BioTrends Research Group, Inc.,released its 1...cation, a,syndicated report offering comprehensive...one and mineral metabolism in Chronic Kidney Disea...tion from 182 US,Nephrologists -- data were collec..., In the renal anemia market, while the use of ES...
(Date:7/25/2008)...rstCall/ -- Caraco Pharmaceutical,Laboratories, Lt...arter of,Fiscal 2009, ended June 30, 2008, of $108...orresponding period of Fiscal 2008. This represent...scal 2008. Pre-tax income grew,to $14.6 million fo...a,pre-tax income of $9.6 million during the corres...
(Date:7/25/2008)...ain Hearing in Both Ears for the First ...25 /- Cochlear, the world,s leader in...landmark milestone when,Dr. Thomas Roland, Jr., MD...0th cochlear implant device procedure. Today, 72-y...dergo surgery to receive bilateral (a,device in ea...
(Date:7/25/2008)...survey on creativity, sponsored by the Jerusalem-b...Teleseker, revealed that a majority of the Israeli...special methods that could "put them into a c...ong as desired." , J... survey on creativity, sponsored by the Jerusalem-...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 2Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 3Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 4Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3
... of manufacturing jobs that have vanished all thro...ore smokestack industries is a fool,s errand. Inst...f companies based on the technological inventions ...cation and private industries. , ,Several economic...nt of assisting these technol with high growth pot...
...licants has been winnowed to 52 in the Second Ann... ,An independent panel of judges selected the surv... The judges were organized through the Wisconsin ...t in conjunction with its membership subsidiary, t...de affiliates. , ,"Our judges were impressed by th...
...d out last week, Mondays Wall Street Journal det..., ,In past columns, we have talked about the conso...nese are actually arriving late to the consolidati...ave been consolidating for years and continue to c...ove that did not acquire other major pharmaceuti...
...here may no yellow tape or chalk outlines of a bod...uter crimes if they want remedies, said a lawyer w... Wednesday. , ,Daniel Vaccaro, a partner with Mic...ose systems have been compromised by Internet frau...earning to work with law enforcement. , ,"You get ...
Other Biology Technology:Will tech transfer save Wisconsin's economy? 2Will tech transfer save Wisconsin's economy? 3Will tech transfer save Wisconsin's economy? 4Will tech transfer save Wisconsin's economy? 5Will tech transfer save Wisconsin's economy? 6Will tech transfer save Wisconsin's economy? 7Will tech transfer save Wisconsin's economy? 8Contest narrows to 52 business plans 2Japan's pharma mergers will trickle to the Midwest 2Japan's pharma mergers will trickle to the Midwest 3Japan's pharma mergers will trickle to the Midwest 4After a successful attack on your computer systems, then what? 2After a successful attack on your computer systems, then what? 3
(Date:7/24/2008)...w study by researchers from Columbia University,s ...he most challenging issues in infant health and pr...countries. In these settings, HIV-infected mother...heir infants, they should exclusively breast-feed,...ter birth. But according to the study conducted in...
(Date:7/24/2008)...4, 2008 In the life of a cell, the response to DN...ause and repair itself, commit suicide, or grow un...study, published in the July 25th issue of Cell ,...ntified a way that cells respond to DNA damage thr... The finding points to a new pathway for the devel...
(Date:7/24/2008)...AUL (July 24, 2008) A multi-institutional team of...ty of Minnesota Medical School, have developed a p...e robust method will allow researchers to generate...DNA sequences for inactivation or repair. , The p...Ph.D., director of the Arnold and Mabel Beckman Ce...
(Date:7/24/2008)...Y, Iowa The University of Iowa and Iowa State Uni...ly enhance both institutions, genetic research cap...hased a massively parallel DNA sequencer an instr...rate of millions to billions of bases in a single ... will be available on a fee-for-service basis to ...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3A new cellular pathway linked to cancer is identified by NYU researchers 2Consortium develops new method to manipulate genetic material 2UI and ISU establish shared DNA sequencing instrumentation 2UI and ISU establish shared DNA sequencing instrumentation 3New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 1New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 2New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 3New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 4New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 5Sinovac Announces Postponement of Annual General Meeting 115 1Sinovac Announces Postponement of Annual General Meeting 115 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 1Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 3Longer ambulance journeys boost death risk for seriously ill patients 116 1Longer ambulance journeys boost death risk for seriously ill patients 116 2
... in the brilliantly colored,hot springs of Yellows..., a discovery University of Colorado at Boulder re...onments on other planets and could,add to understa... CU-Boulder biologists led by Professor Norman Pac... evolution and microbiology,published their repor...
...at broadens our insight into,the cause of certain ...asmus University Medical Center (Rotterdam, The Ne... enzyme-repair system to identify the,principal ty...-tumor,development. The researchers, findings also...developing preventative therapies against skin,can...
... skin and bones, which could,be used to treat burn...igurements, may soon be a reality using inkjets wh...rsity of Manchester have developed the,breakthroug...and bones,to be grown, simply by inputting their d..., Head of the Ink-Jet Printing of Human Cells Proj...
...searchers from the Departments,of Chemical and Env...,Botany and Plant Sciences have worked together to...ates ,to uncover new knowledge about the binding o...rotein plays a critical role along with another,pr...tubes to the eggs,found in ovules. , Applying,nano...
Other Biology News:Yellowstone microbes fueled by hydrogen, according to U. of Colorado study 2Yellowstone microbes fueled by hydrogen, according to U. of Colorado study 3Yellowstone microbes fueled by hydrogen, according to U. of Colorado study 4Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer 2University of Manchester makes made-to-measure skin and bones a reality using inkjet printers 2Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants 2
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds
...y RNA Spikes for the normalization and control of ...ng and for protocol assessment and optimization. C...ybridization stringency and background. Normalize ...Spots, and complementary RNA Spikes for the normal...
Kit for Detection of Mitochondrial Membrane Potential
Biology Products: